{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:27:07Z","timestamp":1784795227928,"version":"3.55.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Background\/Objectives:<\/jats:title>\n            <jats:p>Current guidelines recommend [<jats:sup>18<\/jats:sup>F]FDG PET\/CT as the preferred imaging modality for suspected extramedullary bone plasmacytomas, while whole-body magnetic resonance imaging (WB-MRI) is indicated for solitary bone plasmacytomas. Despite these recommendations, the available evidence comparing the diagnostic efficacy of both techniques remains limited. The aim of this study was to compare the diagnostic efficacy of WB-MRI and [<jats:sup>18<\/jats:sup>F]FDG PET\/CT in the initial evaluation of plasmacytomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We performed a multicenter, observational, and retrospective analysis of patients diagnosed with plasmacytoma who underwent WB-MRI and\/or [<jats:sup>18<\/jats:sup>F]FDG PET\/CT as part of their diagnostic workup. Lesions identified were categorized by anatomic location, and concordance between WB-MRI and [<jats:sup>18<\/jats:sup>F]FDG PET\/CT findings was assessed. The McNemar test and Pearson \u03c7<jats:sup>2<\/jats:sup> test were used to compare detection rates between WB-MRI and [<jats:sup>18<\/jats:sup>F]FDG PET\/CT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The study included 73 patients (33 men) recruited between 2012 and 2023, age range 30\u201394 years (mean 63.4 \u00b1 12.2\u00a0y). Of these, 56 patients underwent both diagnostic tests. Diagnoses revealed solitary plasmacytoma in 16 patients, concurrent multiple myeloma (MM) and plasmacytoma in 18 patients, and plasmacytoma in 22 patients with a prior MM history. Out of the 56 plasmacytomas, 40 were osseous and 16 were extramedullary. WB-MRI detected 98.2% of plasmacytomas compared with 83.9% for [<jats:sup>18<\/jats:sup>F]FDG PET\/CT, with a statistically significant difference of OR 9 (95% CI: 1.2\u2013394.5), <jats:italic toggle=\"yes\">P<\/jats:italic>=0.021. Concordance was very high for osseous plasmacytomas but moderate for extramedullary plasmacytomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>These findings suggest WB-MRI is an alternative to [<jats:sup>18<\/jats:sup>F]FDG PET\/CT for detecting plasmacytomas. A comprehensive clinical and radiologic assessment is essential for the optimal evaluation of patients with plasmacytoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005954","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T05:00:09Z","timestamp":1747371609000},"page":"695-706","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Whole-body MRI Versus [18F]FDG PET\/CT in Diagnosing and Monitoring Plasmacytomas"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-3015","authenticated-orcid":false,"given":"Nieves","family":"G\u00f3mez Le\u00f3n","sequence":"first","affiliation":[{"name":"School of Medicine, Universidad Aut\u00f3noma de Madrid"},{"name":"Department of Radiology, Instituto de Investigaci\u00f3n Sanitaria (IIS)-Princesa, Hospital Universitario de La Princesa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7933-6004","authenticated-orcid":false,"given":"Isabel","family":"Vicu\u00f1a-Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Haematology, Hospital Universitario de La Princesa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-0968","authenticated-orcid":false,"given":"Beatriz","family":"Aguado-Bueno","sequence":"additional","affiliation":[{"name":"Department of Haematology, Hospital Universitario de La Princesa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7730-5013","authenticated-orcid":false,"given":"Francisco","family":"Garrido-Enjamio","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad Aut\u00f3noma de Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7917-6436","authenticated-orcid":false,"given":"Itxaso","family":"Gal\u00e1n-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital Universitario Infanta Leonor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Castillo-Morales","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-822X","authenticated-orcid":false,"given":"Adri\u00e1n","family":"Alegre Amor","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad Aut\u00f3noma de Madrid"},{"name":"Department of Haematology, Hospital Universitario de La Princesa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8071-6513","authenticated-orcid":false,"given":"Roberto C.","family":"Delgado Bolton","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logro\u00f1o, La Rioja, Spain"},{"name":"Servicio C\u00e1ntabro de Salud, Santander, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"R1-20250630","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"R2-20250630","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"R3-20250630","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/diagnostics13091570","article-title":"Multitracer PET\/CT with [18F]Fluorodeoxiglucose and [18F]Fluorocholine in the initial staging of multiple myeloma patients applying the impetus criteria: a pilot study","volume":"13","author":"Garrastachu Zumar\u00e1n","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R4-20250630","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","article-title":"Solitary plasmacytoma of bone and asymptomatic multiple myeloma","volume":"96","author":"Dimopoulos","year":"2000","journal-title":"Blood"},{"key":"R5-20250630","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.20.00386","article-title":"Standardization of 18F-FDG-PET\/CT according to deauville criteria for metabolic complete response definition in newly diagnosed multiple myeloma","volume":"39","author":"Zamagni","year":"2021","journal-title":"J Clin Oncol"},{"key":"R6-20250630","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/ejh.12907","article-title":"Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register","volume":"99","author":"Nahi","year":"2017","journal-title":"Eur J Haematol"},{"key":"R7-20250630","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-017-0549-1","article-title":"Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel","volume":"11","author":"Caers","year":"2018","journal-title":"J Hematol Oncol"},{"key":"R8-20250630","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"R9-20250630","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bjh.17338","article-title":"Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations","volume":"194","author":"Rosi\u00f1ol","year":"2021","journal-title":"Br J Haematol"},{"key":"R10-20250630","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20250630","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol"},{"key":"R12-20250630","first-page":"841","article-title":"Positron emission tomography (PET) for staging of solitary plasmacytoma","volume":"18","author":"Schirrmeister","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"key":"R13-20250630","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3324\/haematol.12654","article-title":"FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma","volume":"93","author":"Salaun","year":"2008","journal-title":"Haematologica"},{"key":"R14-20250630","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00259-017-3810-5","article-title":"18F-FDG PET\/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma","volume":"45","author":"Albano","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-20250630","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40644-018-0152-x","article-title":"The role of initial 18F-FDG PET\/CT in the management of patients with suspected extramedullary plasmocytoma","volume":"18","author":"Zhang","year":"2018","journal-title":"Cancer Imaging"},{"key":"R16-20250630","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ijrobp.2008.08.037","article-title":"Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma","volume":"74","author":"Kim","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20250630","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1200\/JCO.1993.11.7.1311","article-title":"Magnetic resonance imaging in the staging of solitary plasmacytoma of bone","volume":"11","author":"Moulopoulos","year":"1993","journal-title":"J Clin Oncol"},{"key":"R19-20250630","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/RLU.0000000000003512","article-title":"Agreement between 18F-FDG PET\/CT and whole-body magnetic resonance compared with skeletal survey for initial staging and response at end-of-treatment evaluation of patients with multiple myeloma","volume":"46","author":"G\u00f3mez Le\u00f3n","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R20-20250630","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4103\/0366-6999.231513","article-title":"IgA type multiple myeloma, clinical features, and prognosis","volume":"131","author":"Wang","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"R21-20250630","first-page":"41","article-title":"Describing IgA myeloma: an immunophenotypic and molecular approach","volume":"105","author":"Akgun","year":"2022","journal-title":"R I Med J (2013)"},{"key":"R22-20250630","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiol.2019181949","article-title":"Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS)","volume":"291","author":"Messiou","year":"2019","journal-title":"Radiology"},{"key":"R23-20250630","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/hemato2040044","article-title":"Diffusion-weighted MRI\u2014the way forward for MRI in myeloma?","volume":"2","author":"Hillengass","year":"2021","journal-title":"Hemato"},{"key":"R24-20250630","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.diii.2021.05.009","article-title":"Comparison of conventional magnetic resonance imaging and diffusion-weighted imaging in the differentiation of bone plasmacytoma from bone metastasis in the extremities","volume":"102","author":"Hwang","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"R25-20250630","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3941\/jrcr.v10i2.2418","article-title":"Apparent diffusion coefficient map of a case of extramedullary plasmacytoma","volume":"10","author":"Ramachandran","year":"2016","journal-title":"J Radiol Case Rep"},{"key":"R26-20250630","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3174\/ajnr.A5528","article-title":"Review of the imaging features of benign osteoporotic and malignant vertebral compression fractures","volume":"39","author":"Mauch","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"R27-20250630","first-page":"20180033","article-title":"Differential diagnosis of benign and malignant vertebral compression fractures using conventional and advanced MRI techniques","volume":"1","author":"Romeo","year":"2019","journal-title":"BJR Open"},{"key":"R28-20250630","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1148\/radiology.207.2.9577479","article-title":"Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures","volume":"207","author":"Baur","year":"1998","journal-title":"Radiology"},{"key":"R29-20250630","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3348\/kjr.2016.17.5.590","article-title":"Single-Shot Echo-Planar diffusion-weighted MR imaging at 3T and 1.5T for differentiation of benign vertebral fracture edema and tumor infiltration","volume":"17","author":"Park","year":"2016","journal-title":"Korean J Radiol"},{"issue":"suppl 1)","key":"R30-20250630","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1007\/s00586-012-2227-x","article-title":"Diffusion-weighted MR imaging in differentiation between osteoporotic and neoplastic vertebral fractures","volume":"21","author":"Pozzi","year":"2012","journal-title":"Eur Spine J"},{"key":"R31-20250630","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","article-title":"Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement","volume":"33","author":"Dimopoulos","year":"2015","journal-title":"J Clin Oncol"},{"key":"R32-20250630","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/RLU.0000000000001718","article-title":"Multicenter comparison of contrast-enhanced FDG PET\/CT and 64-slice multi-detector-row CT for initial staging and response evaluation at the end of treatment in patients with lymphoma","volume":"42","author":"G\u00f3mez Le\u00f3n","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R33-20250630","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/hematology.2019000080","article-title":"What to do with minimal residual disease testing in myeloma","volume":"2019","author":"Manasanch","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R34-20250630","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41408-023-00794-x","article-title":"Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients","volume":"13","author":"Fonseca","year":"2023","journal-title":"Blood Cancer J"},{"key":"R35-20250630","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00259-023-06406-x","article-title":"International EANM-SNMMI-ISMRM consensus recommendation for PET\/MRI in oncology","volume":"50","author":"Veit-Haibach","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R36-20250630","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/RLU.0000000000004062","article-title":"New biomarkers with prognostic impact based on multitracer PET\/CT imaging in neuroendocrine neoplasms: the light leading out of the darkness in challenging tumors","volume":"47","author":"Delgado Bolton","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R37-20250630","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/RLU.0000000000004357","article-title":"The concept of strength through synergy applied to the search of powerful prognostic biomarkers in gastroesophageal cancer: an example based on combining clinicopathological parameters, imaging-derived sarcopenia measurements, and radiomic features","volume":"48","author":"Delgado Bolton","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R38-20250630","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s00259-017-3913-z","article-title":"Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse","volume":"45","author":"Delgado Bolton","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:00:53Z","timestamp":1751299253000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005954"}},"subtitle":["A Comparative Study"],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005954","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"2025-03-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}